Teva Pharma (TEVA) PT Lowered to $16.50 at Wells Fargo

February 9, 2018 8:05 AM EST Send to a Friend

Wells Fargo lowered its price target on Teva Pharma (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Teva Pharma (TEVA) PT Lowered to $16.50 at Wells Fargo

Member Login

Free News Feed